$38.81 -0.01 (-0.03%)
2/13/2012 10:39 AM

Eli Lilly & Co. (NYSE:LLY)

CAPS Rating: 4 out of 5

The Company discovers, develops, manufactures and sells products in one of its business segment of pharmaceutical products to prevent and treat human diseases.

Featured Broker Partners


Advertisement